CNBX Pharmaceuticals Aktie Logo
US13764M2098
A3DK5G
CNBX

CNBX Pharmaceuticals Aktie

Dividend yield TTM
0.00%
€0.00/share
Dividend growth (CAGR 5Y)
-
Next dividend
It is unlikely that any further dividends will be paid.

Upcoming dividends delivered straight to your inbox

Historical dividends

In 2022, CNBX Pharmaceuticals Aktie has already paid €22.85 in dividends. The last payout was in April 2022.

Tools for dividend investors

Dividend metrics Metrics

All metrics All
Metric Value
Price
€0.0000863
Yield
0.00%
Interval
Yearly
CAGR 3Y
-
CAGR 5Y
-
CAGR 10Y
-

All dividend data

CNBX Pharmaceuticals Aktie has not paid a dividend in the last 3 years. It is therefore likely that no further dividends will be paid.

New dividends delivered straight to your inbox
Ex-dividend date
Payment date
Distribution
YoY
Yield
2022 €22.85 9.91% 1,317.86%
01/28/2022 04/28/2022 €22.85
2000 €20.79 0.00% -
03/28/2000 €20.79

Frequently asked questions

When were the most recent dividend payment dates for CNBX Pharmaceuticals Aktie?

The most recent payment was made on 04/28/2022.

When did you need to hold CNBX Pharmaceuticals Aktie in your portfolio to receive the latest dividend?

If you held CNBX Pharmaceuticals Aktie in your portfolio on 01/28/2022, you received the payout.

When is the next dividend from CNBX Pharmaceuticals Aktie expected?

As CNBX Pharmaceuticals Aktie has not paid a dividend in the last 3 years, it is unlikely to pay another dividend.

More dividend stocks

All dividends in the calendar
Name Interval
Yield
CAGR 5Y
Rubis Logo
FR0013269123
A2DUVQ
Y 6.17% 3.01%
Voltratron AG Logo
DE000A2E4LE9
A2E4LE
- 0.00% -
Intesa Sanpaolo Logo
IT0000072618
850605
H 5.55% -
Hecla Mining Logo
US4227041062
854693
Q 0.07% 0.93%
Nextera Energy Logo
US65339F1012
A1CZ4H
Q 2.91% 10.35%
ArcelorMittal Logo
LU1598757687
A2DRTZ
Q 0.89% -
Target Logo
US87612E1064
856243
Q 2.77% 11.83%
Engie Logo
FR0010208488
A0ER6Q
Y 5.51% -
Qualcomm Logo
US7475251036
883121
Q 2.19% 6.63%
Nike Logo
US6541061031
866993
Q 4.11% 5.65%
🍪

Parqet  uses cookies. Learn more